Baystate Wealth Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-4
Closed 614
2019
Q4
$0 Buy
+4
New +$66 ﹤0.01% 627
2019
Q3
Sell
-51
Closed -$1K 583
2019
Q2
$1K Hold
51
﹤0.01% 545
2019
Q1
$2K Buy
51
+1
+2% +$36 ﹤0.01% 495
2018
Q4
$2K Hold
50
﹤0.01% 499
2018
Q3
$2K Hold
50
﹤0.01% 511
2018
Q2
$2K Sell
50
-55
-52% -$2.74K ﹤0.01% 530
2018
Q1
$5K Hold
105
﹤0.01% 416
2017
Q4
$6K Sell
105
-25
-19% -$1.31K ﹤0.01% 404
2017
Q3
$7K Hold
130
﹤0.01% 374
2017
Q2
$6K Hold
130
﹤0.01% 387
2017
Q1
$5K Hold
130
﹤0.01% 386
2016
Q4
$3K Buy
+130
New +$2.67K ﹤0.01% 384

Other funds holding CC

Baystate Wealth Management's CC Position: Q1 2020 in Review

Baystate Wealth Management sold out of Chemours (CC) in Q1 2020, closing a stake of 4 shares.

Baystate Wealth Management first reported a position in CC in Q4 2016 and held it in 12 quarters. The position peaked at $7K in Q3 2017. 416 funds tracked by Wall St. Rank hold CC as of Q1 2020.

  • Baystate Wealth Management reported no remaining Chemours position as of Q1 2020 after selling out during the quarter.
  • Baystate Wealth Management sold 4 Chemours shares in Q1 2020.
  • Baystate Wealth Management first reported a position in Chemours in Q4 2016 and held it in 12 quarters.
  • Baystate Wealth Management's Chemours position peaked at $7K in Q3 2017.
  • 416 funds tracked by Wall St. Rank held Chemours as of Q1 2020.

Based on Baystate Wealth Management's 13F filing for Q1 2020, filed 22 Apr 2020.